04 June 2022 : Clinical Research
Screening for SARS-CoV-2 Infection in Students at the Medical University of Warsaw, Poland Between November 15 and December 10, 2021 Using a Single Lateral Flow Test, the Panbio™ COVID-19 Ag Rapid Test
Mariusz Gujski1ABCDEG, Paulina Mularczyk-Tomczewska1BCDEF*, Filip Raciborski2ABCDE, Piotr Samel-Kowalik2ABCDE, Łukasz Samoliński
3ADE, Dorota Olczak-Kowalczyk4ABDE, Mateusz Jankowski 5ABCDEF
DOI: 10.12659/MSM.936962
Med Sci Monit 2022; 28:e936962
Table 2 Characteristics of the study population by rapid antigen test result (n=423).
| Variable | Overalln=423n (%) | Positive subjectsn=15n (%) | Negative subjectsn=408n (%) | p |
|---|---|---|---|---|
| 23.08±2.2 [–]19 | 21.67±1.05 [–]20 | 23.13±2.2 [–]19 | 0.011 | |
| Female | 276 (65.2) | 13 (86.7) | 263 (64.5) | 0.098 |
| Male | 147 (34.8) | 2 (13.3) | 145 (38.5) | |
| Dentistry | 73 (17.3) | 5 (33.3) | 68 (16.7) | <0.001 |
| Nursing | 39 (9.2) | 6 (40.0) | 33 (8.1) | |
| Medicine | 285 (67.4) | 3 (20.0) | 282 (69.1) | |
| Other medical faculties | 26 (6.1) | 1 (6.7) | 25 (6.1) | |
| Vaccinated | 416 (98.3) | 14 (93.3) | 402 (98.5) | 0.225 |
| AstraZeneca vaccine | 54 (13.0) | 6 (42.9) | 48 (11.9) | <0.05 |
| Johnson&Johnson vaccine (single dose) | 5 (1.2) | 0 (0.0) | 5 (1.2) | |
| Moderana vaccine | 4 (0.9) | 0 (0.0) | 4 (1.0) | |
| Pfizer vaccine | 353 (84.9) | 8 (57.1) | 345 (85.8) | |
| One | 7 (1.7) | 0 (0.0) | 7 (1.7) | <0.001 |
| Two | 145 (34.8) | 12 (85.7) | 133 (33.1) | |
| Three | 264 (63.5) | 2 (14.3) | 262 (65.2) | |
| Yes | 207 (48.9) | 4 (26.7) | 203 (49.8) | 0.113 |
| Yes, once | 102 (24.1) | 1 (6.7) | 101 (24.8) | 0.182 |
| Yes, many times | 124 (29.3) | 4 (26.7) | 120 (29.4) | |
| No, never | 197 (46.6) | 10 (66.7) | 187 (45.8) | |
| Yes | 47 (11.1) | 1 (6.7) | 46 (11.3) | 0.2 |
| FFP2 or FFP3 | 165 (39.0) | 1 (6.7) | 164 (40.2) | <0.01 |
| Surgical masks | 401 (94.8) | 14 (93.3) | 387 (94.9) | 0.557 |
| Reusable material masks | 73 (17.3) | 3 (20.0) | 70 (17.2) | 0.730 |
| None | 2 (0.5) | 0 (0.0) | 2 (0.05) | 1.000 |
| 1–2 times a day | 235 (55.8) | 10 (66.7) | 225 (55.4) | 0.1 |
| 3–4 times a day | 35 (8.3) | 3 (20.0) | 32 (7.9) | |
| 5–6 times a day | 1 (0.2) | 0 (0.0) | 1 (0.2) | |
| I do not change/I use one facemask all day | 150 (35.6) | 2 (13.3) | 148 (36.5) | |
| Living alone | 92 (21.7) | 3 (20.0) | 89 (21.8) | 0.719 |
| Living with 1 person | 169 (40.0) | 6 (40.0) | 163 (40.0) | |
| Living with 2 people | 84 (19.9) | 2 (13.3) | 82 (20.1) | |
| Living with 3 people | 52 (12.3) | 2 (13.3) | 50 (12.3) | |
| Living with 4 or more people | 26 (6.1) | 2 (13.3) | 24 (5.9) | |
| Currently employed | 177 (41.8) | 3 (20.0) | 174 (42.6) | 0.110 |
| Only student (without additional work) | 246 (58.2) | 12 (80.0) | 234 (57.4) | |
| Yes | 60 (14.2) | 1 (33.3) | 69 (33.9) | 1.000 |
| Not at all | 37 (8.7) | 2 (13.3) | 35 (8.6) | 0.151 |
| 1–2 days | 30 (7.1) | 0 (0.0) | 30 (7.4) | |
| 3–4 days | 70 (16.5) | 3 (20.0) | 67 (16.4) | |
| 5–6 days | 121 (28.6) | 1 (6.7) | 120 (29.4) | |
| Yes, daily | 165 (39.0) | 9 (60.0) | 156 (38.2) | |
| SD – standard deviation. | ||||